Chloroprocaine Spinal Anesthesia for Cervical Cerclage (CP Spinal)

Completed · Phase 4

Conditions studied: Adverse Reaction to Spinal Anesthetic, Maternal Care for Cervical Incompetence

In brief

This study aims to determine whether or not spinal anesthesia with the local anesthetic drug, chloroprocaine, wears off faster than the local anesthetic drug, bupivacaine, and results in faster discharge from the post-anesthesia care unit after surgery.

Key facts

Study ID

NCT02862912

Run by

Columbia University

People needed

43

Starts

2016-11-08

Expected to finish

2020-01-31

Last updated by the study team

2020-12-24

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• ASA I and II women
• 18-45 yrs old
• Singleton pregnancy
• Cervical cerclage 1st or 2nd trimester of pregnancy undergoing with spinal anesthesia
• Height 150 - 180 cm
• BMI ≤ 40 kg/m2.

You may not qualify if…

• Any contraindication to neuraxial anesthesia (history of neurologic disease (e.g., multiple sclerosis, spinal stenosis, central or peripheral neuropathy)
• Pre-existing/chronic back pain
• Ester local anesthetic allergy, PABA allergy
• History of atypical cholinesterase (CP is metabolized by cholinesterase)

Where it is running

• New York Presbyterian Hospital — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.